|
1
|
Lin FC, Medendorp A, Van Kuiken M, Mills SA, Tarnay CM. Vaginal Dehiscence and Evisceration After Robotic-assisted Radical Cystectomy: A Case Series and Review of the Literature. Urology 2019; 134:90-96. [DOI: 10.1016/j.urology.2019.09.009] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2019] [Revised: 09/05/2019] [Accepted: 09/10/2019] [Indexed: 12/16/2022]
|
|
2
|
Bertolo R, Agudelo J, Garisto J, Armanyous S, Fergany A, Kaouk J. Perioperative Outcomes and Complications after Robotic Radical Cystectomy With Intracorporeal or Extracorporeal Ileal Conduit Urinary Diversion: Head-to-head Comparison From a Single-Institutional Prospective Study. Urology 2019; 129:98-105. [DOI: 10.1016/j.urology.2018.11.059] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2018] [Revised: 11/18/2018] [Accepted: 11/30/2018] [Indexed: 01/24/2023]
|
|
3
|
Aragon-Ching JB, Werntz RP, Zietman AL, Steinberg GD. Multidisciplinary Management of Muscle-Invasive Bladder Cancer: Current Challenges and Future Directions. Am Soc Clin Oncol Educ Book 2018; 38:307-318. [PMID: 30231340 DOI: 10.1200/edbk_201227] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
The treatment of muscle-invasive bladder cancer (MIBC) is complex and requires a multidisciplinary collaboration among surgery, radiation, and medical oncology. Although neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) and lymph node dissection has been considered the standard treatment for MIBC, many patients are unfit for surgery or cisplatin-ineligible, and considerations for bladder-preservation strategies not only are increasingly recognized as optimal treatment alternatives, but also should feature in the range of management options presented to patients at the time of diagnosis. Apart from chemotherapy, immunotherapy has also been used with success in locally advanced and metastatic bladder cancer and is moving into the MIBC space. Prospective studies addressing trends in management that span systemic, surgical, and radiation options for patients are discussed in this article.
Collapse
Affiliation(s)
- Jeanny B Aragon-Ching
- From the Genitourinary Medical Oncology, Inova Schar Cancer Institute, Fairfax, VA; Department of Surgery, Section of Urology, The University of Chicago Medicine, Chicago, IL; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
| | - Ryan P Werntz
- From the Genitourinary Medical Oncology, Inova Schar Cancer Institute, Fairfax, VA; Department of Surgery, Section of Urology, The University of Chicago Medicine, Chicago, IL; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
| | - Anthony L Zietman
- From the Genitourinary Medical Oncology, Inova Schar Cancer Institute, Fairfax, VA; Department of Surgery, Section of Urology, The University of Chicago Medicine, Chicago, IL; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
| | - Gary D Steinberg
- From the Genitourinary Medical Oncology, Inova Schar Cancer Institute, Fairfax, VA; Department of Surgery, Section of Urology, The University of Chicago Medicine, Chicago, IL; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
| |
Collapse
|
|
4
|
Khetrapal P, Tan WS, Kelly JD. Factors Affecting the Cost of Radical Cystectomy in the USA: Some Centres Are More Equal than Others. Eur Urol 2017; 73:383-384. [PMID: 29174579 DOI: 10.1016/j.eururo.2017.11.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2017] [Accepted: 11/07/2017] [Indexed: 11/18/2022]
Affiliation(s)
- Pramit Khetrapal
- Division of Surgery and Interventional Science, University College London, London, UK; Department of Urology, University College London Hospital, London, UK.
| | - Wei Shen Tan
- Division of Surgery and Interventional Science, University College London, London, UK; Department of Urology, University College London Hospital, London, UK
| | - John D Kelly
- Division of Surgery and Interventional Science, University College London, London, UK; Department of Urology, University College London Hospital, London, UK
| |
Collapse
|